These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3069983)

  • 1. Pharmacological adjuncts in the treatment of opioid and cocaine addicts.
    Herridge P; Gold MS
    J Psychoactive Drugs; 1988; 20(3):233-42. PubMed ID: 3069983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cocaine abuse: pharmacotherapy.
    Kleber HD
    Ciba Found Symp; 1992; 166():195-200; discussion 200-6. PubMed ID: 1638913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine attenuates the severity of naloxone-precipitated opioid withdrawal.
    Kosten TA
    Life Sci; 1990; 47(18):1617-23. PubMed ID: 2250575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights and treatments: opiate withdrawal and cocaine addiction.
    Gold MS; Dackis CA
    Clin Ther; 1984; 7(1):6-21. PubMed ID: 6394130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine abuse and adult attention deficit disorder.
    Cocores JA; Davies RK; Mueller PS; Gold MS
    J Clin Psychiatry; 1987 Sep; 48(9):376-7. PubMed ID: 3624209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evidence of new opioid modulators for the treatment of addiction.
    Rodríguez-Arias M; Aguilar MA; Manzanedo C; Miñarro J
    Expert Opin Investig Drugs; 2010 Aug; 19(8):977-94. PubMed ID: 20629615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central stimulant abuse: neurochemistry and pharmacotherapy.
    Dackis CA; Gold MS; Pottash AL
    Adv Alcohol Subst Abuse; 1986; 6(2):7-21. PubMed ID: 2886014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
    Heidbreder CA; Hagan JJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
    Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological approaches to cocaine addiction.
    Dackis CA; Gold MS
    J Subst Abuse Treat; 1985; 2(3):139-45. PubMed ID: 3912517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic neuropharmacology of cocaine: progress in pharmacotherapy.
    Gawin FH
    J Clin Psychiatry; 1988 Feb; 49 Suppl():11-6. PubMed ID: 3276669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications development at the National Institute on Drug Abuse: focus on cocaine.
    Johnson DN; Vocci FJ
    NIDA Res Monogr; 1993; 135():57-70. PubMed ID: 8289904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine-desipramine protocol in treatment of cocaine addiction.
    Giannini AJ; Billett W
    J Clin Pharmacol; 1987 Aug; 27(8):549-54. PubMed ID: 3308977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.
    Mathon DS; Lesscher HM; Gerrits MA; Kamal A; Pintar JE; Schuller AG; Spruijt BM; Burbach JP; Smidt MP; van Ree JM; Ramakers GM
    Neuroscience; 2005; 130(2):359-67. PubMed ID: 15664692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of naltrexone in the treatment of opiate addicts. Efficacy and indications for type categories].
    Faro G; Jarre P; Martucci M; Sargiotto A; Eandi M
    Clin Ter; 1991 Nov 15-30; 139(3-4):93-9. PubMed ID: 1837256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine addiction as a neurological disorder: implications for treatment.
    Majewska MD
    NIDA Res Monogr; 1996; 163():1-26. PubMed ID: 8809851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine and other indirect-acting monoamine agonists differentially attenuate a naltrexone discriminative stimulus in morphine-treated rhesus monkeys.
    McMahon LR; Sell SL; France CP
    J Pharmacol Exp Ther; 2004 Jan; 308(1):111-9. PubMed ID: 14569055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.